rosiglitazone has been researched along with Anemia, Sickle Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archer, D; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, K; Sutliff, RL | 1 |
1 other study(ies) available for rosiglitazone and Anemia, Sickle Cell
Article | Year |
---|---|
Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
Topics: Anemia, Sickle Cell; Animals; Blood Pressure; Endothelial Cells; Endothelin-1; Gene Knockdown Techniques; Hemin; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Ligands; Lung; Mice; MicroRNAs; Models, Biological; PPAR gamma; Proto-Oncogene Protein c-ets-1; Pulmonary Artery; Rosiglitazone; Systole; Thiazolidinediones; Up-Regulation | 2017 |